However, higher inhibitory activities were observed in HCC827 (EGFR del19), PC9 (EGFR del19), and NCI-H1975 (EGFR L858R/T790M) cancer cell lines harboring an EGFR mutation (IC50 = 3.3–4.1 nM). The gene discussed is EGFR; the disease is cancer.